1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL MEDICAL FLUID BAGS MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Dialysis Bags
5.3. Drain Bags
5.4. Blood Bags
5.5. Intravenous Bags
5.6. Others
6. GLOBAL MEDICAL FLUID BAGS MARKET BY MATERIAL
6.1. Introduction
6.2. PVC (Polyvinyl Chloride) Bags
6.3. Non-PVC Bags
6.3.1. Polypropylene (PP) Bags
6.3.2. Polyethylene (PE) Bags
6.3.3. Ethylene Vinyl Acetate (EVA) Bags
6.3.4. Thermoplastic Polyurethane (TPU) Bags
6.4. Others
7. GLOBAL MEDICAL FLUID BAGS MARKET BY USAGE TYPE
7.1. Introduction
7.2. Single-Use Medical Fluid Bags
7.3. Reusable Medical Fluid Bags
8. GLOBAL MEDICAL FLUID BAGS MARKET BY END-USER
8.1. Introduction
8.2. Hospitals
8.3. Ambulatory Surgical Centers (ASCs)
8.4. Others
9. GLOBAL MEDICAL FLUID BAGS MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Italy
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Taiwan
9.6.8. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Technoflex
11.2. Fresenius Kabi AG
11.3. SB-KAWASUMI LABORATORIES, INC.
11.4. B. Braun Melsungen AG
11.5. Terumo Corporation
11.6. Amsino International, Inc.
11.7. Coloplast A/S
11.8. SIPPEX Medical Bags
11.9. ICU Medical Inc.
11.10. Dow
11.11. Grifols, S.A.
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES